114 related articles for article (PubMed ID: 25041870)
21. Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms.
Strbian D; Piironen K; Meretoja A; Sairanen T; Putaala J; Tiainen M; Artto V; Rantanen K; Häppölä O; Kaste M; Lindsberg PJ;
Int J Stroke; 2013 Jul; 8(5):293-9. PubMed ID: 22568877
[TBL] [Abstract][Full Text] [Related]
22. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W
Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525
[TBL] [Abstract][Full Text] [Related]
23. Association between Baseline NIHSS Limb Motor Score and Functional Recovery after Stroke: Analysis Based on a Multicountry Dataset.
Chen CLH; Pokharkar Y; Venketasubramanian N;
Cerebrovasc Dis; 2023; 52(2):160-165. PubMed ID: 35908546
[TBL] [Abstract][Full Text] [Related]
24. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of MLC601 on functional recovery after stroke: A systematic review and meta-analysis of randomized controlled trials.
González-Fraile E; Martín-Carrasco M; Ballesteros J
Brain Inj; 2016; 30(3):267-70. PubMed ID: 26890534
[TBL] [Abstract][Full Text] [Related]
26. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effect of dapsone in patients with acute ischemic stroke: a pilot study.
Nader-Kawachi J; Góngora-Rivera F; Santos-Zambrano J; Calzada P; Ríos C
Neurol Res; 2007 Apr; 29(3):331-4. PubMed ID: 17509235
[TBL] [Abstract][Full Text] [Related]
28. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
[TBL] [Abstract][Full Text] [Related]
29. Does symptom onset to primary stroke center time goals affect stroke outcome?
Chee B; Raman R; Ernstrom K; Guzik AK; Hemmen TM; Rapp KS; Meyer BC; Meyer DM
J Stroke Cerebrovasc Dis; 2014; 23(5):993-1000. PubMed ID: 24103670
[TBL] [Abstract][Full Text] [Related]
30. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
31. Onset headache predicts good outcome in patients with first-ever ischemic stroke.
Chen PK; Chiu PY; Tsai IJ; Tseng HP; Chen JR; Yeh SJ; Yeh SJ; Sheu JJ; Chung CP; Wu MH; Hu CJ; Chang CY; Wei CY; Yip PK; Sung SF; Wang SJ; Hsu CY;
Stroke; 2013 Jul; 44(7):1852-8. PubMed ID: 23704109
[TBL] [Abstract][Full Text] [Related]
32. A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional chinese medicine Neuroaid (MLC 601) in enhancing recovery after stroke (TIERS).
Kong KH; Wee SK; Ng CY; Chua K; Chan KF; Venketasubramanian N; Chen C
Cerebrovasc Dis; 2009; 28(5):514-21. PubMed ID: 19816018
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo.
Heurteaux C; Gandin C; Borsotto M; Widmann C; Brau F; Lhuillier M; Onteniente B; Lazdunski M
Neuropharmacology; 2010 Jun; 58(7):987-1001. PubMed ID: 20064536
[TBL] [Abstract][Full Text] [Related]
34. Primary end-point times, functional outcome and adverse event profile after acute ischaemic stroke.
Ali M; Sacco RL; Lees KR;
Int J Stroke; 2009 Dec; 4(6):432-42. PubMed ID: 19930052
[TBL] [Abstract][Full Text] [Related]
35. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.
Dávalos A; Castillo J; Alvarez-Sabín J; Secades JJ; Mercadal J; López S; Cobo E; Warach S; Sherman D; Clark WM; Lozano R
Stroke; 2002 Dec; 33(12):2850-7. PubMed ID: 12468781
[TBL] [Abstract][Full Text] [Related]
36. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
[TBL] [Abstract][Full Text] [Related]
37. Thrombolytic therapy for acute ischemic stroke after recent transient ischemic attack.
Alonso de Leciñana M; Fuentes B; Masjuan J; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Egido JA
Int J Stroke; 2012 Apr; 7(3):213-8. PubMed ID: 22098785
[TBL] [Abstract][Full Text] [Related]
38. Initial Glasgow Coma Scale score predicts outcome following thrombolysis for posterior circulation stroke.
Tsao JW; Hemphill JC; Johnston SC; Smith WS; Bonovich DC
Arch Neurol; 2005 Jul; 62(7):1126-9. PubMed ID: 16009770
[TBL] [Abstract][Full Text] [Related]
39. External validation of the DRAGON score in an elderly Spanish population: prediction of stroke prognosis after IV thrombolysis.
Giralt-Steinhauer E; Rodríguez-Campello A; Cuadrado-Godia E; Ois Á; Jiménez-Conde J; Soriano-Tárraga C; Roquer J
Cerebrovasc Dis; 2013; 36(2):110-4. PubMed ID: 24029547
[TBL] [Abstract][Full Text] [Related]
40. Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial.
Lai X; Cao K; Kong L; Liu Q; Gao Y;
Trials; 2017 Oct; 18(1):479. PubMed ID: 29037226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
